LIFE:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund Hedged Units (CAD)

COMMON STOCK | |

Last Closing

CAD 21.44

Change

-0.15 (-0.69)%

Market Cap

CAD 0.01B

Volume

0.04M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-02 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
TD-PFB:CA Toronto Dominion Bank Pref B

+0.01 (+0.04%)

CAD 201.44B
TD-PFD:CA Toronto Dominion Bank Pref D

-0.15 (-0.62%)

CAD 171.32B
TD-PFI:CA Toronto-Dominion Bank Pref Ser..

-0.04 (-0.16%)

CAD 161.26B
TD-PFM:CA Toronto-Dominion Bank Pref Ser..

N/A

CAD 143.36B
ENB-PFV:CA Enbridge Inc Pref 5

+0.06 (+0.27%)

CAD 110.98B
ENB-PFA:CA Enbridge Inc Pref 9

+0.05 (+0.27%)

CAD 110.83B
ENB-PFC:CA Enbridge Inc Pref 11

N/A

CAD 106.11B
ENB-PFG:CA Enbridge Inc Pref 15

+0.14 (+0.81%)

CAD 102.21B
ENB-PFU:CA Enbridge Inc Pref L

+0.09 (+0.43%)

CAD 81.25B
PPL-PFA:CA Pembina Pipeline Corp Pref Ser..

+0.25 (+1.09%)

CAD 9.12B

ETFs Containing LIFE:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.13% N/A N/A 43% F
Dividend Return 1.54% N/A N/A 51% F
Total Return 4.67% N/A N/A 43% F
Trailing 12 Months  
Capital Gain 1.42% N/A N/A 33% F
Dividend Return 1.51% N/A N/A 35% F
Total Return 2.93% N/A N/A 31% F
Trailing 5 Years  
Capital Gain 7.25% N/A N/A 47% F
Dividend Return 6.33% N/A N/A 28% F
Total Return 13.58% N/A N/A 44% F
Average Annual (5 Year Horizon)  
Capital Gain 1.22% N/A N/A 46% F
Dividend Return 2.35% N/A N/A 45% F
Total Return 1.12% N/A N/A 40% F
Risk Return Profile  
Volatility (Standard Deviation) 7.16% N/A N/A 79% B-
Risk Adjusted Return 32.77% N/A N/A 56% F
Market Capitalization 0.01B N/A N/A 9% A-

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike